Vitiligo treated with oral baricitinib and heliotherapy: A case series

Ann Dermatol Venereol. 2024 Sep;151(3):103300. doi: 10.1016/j.annder.2024.103300. Epub 2024 Jul 17.

Authors

R Reviron¹, E Joly¹, A Bertolotti²

Affiliations

¹ CHU Réunion, Service des Maladies Infectieuses - Dermatologie, Saint Pierre, La Réunion, France.
² CHU Réunion, Service des Maladies Infectieuses - Dermatologie, Saint Pierre, La Réunion, France; Inserm CIC1410, CHU Réunion, Saint Pierre, La Réunion, France. Electronic address: antoine_bertolotti@yahoo.fr.

PMID: 39024810
DOI: 10.1016/j.annder.2024.103300

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Administration, Oral
Adult
Azetidines* / administration & dosage
Azetidines* / therapeutic use
Combined Modality Therapy
Female
Humans
Male
Middle Aged
Phototherapy
Purines* / administration & dosage
Purines* / therapeutic use
Pyrazoles* / administration & dosage
Pyrazoles* / therapeutic use
Sulfonamides* / administration & dosage
Sulfonamides* / therapeutic use
Vitiligo* / drug therapy
Vitiligo* / therapy

Substances

baricitinib
Azetidines
Sulfonamides
Purines
Pyrazoles